Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Epilepsy Behav ; 109: 107128, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32417383

RESUMEN

OBJECTIVE: The goal of this study was to identify a strategy for antiepileptic drug (AED) reduction to allow efficient recording of focal seizures (FS) in patients undergoing video-electroencephalography (EEG) in an epilepsy monitoring unit (EMU) while avoiding the risk of complications associated with more severe seizure types. METHODS: We retrospectively reviewed consecutive patients admitted to our institution's EMU from July 1, 2016 to December 31, 2017. We included 114 presurgical patients who had AEDs reduced and at least one seizure during the admission. We compared AED dosages at which FS versus focal to bilateral tonic-clonic seizures (f-BTCS), seizure clusters, and lorazepam administration occurred. We also examined rate of AED reduction and seizure types. We used a receiver-operating characteristic (ROC) curve to identify a dose maximizing FS and minimizing other seizure types. RESULTS: Antiepileptic drug withdrawal rates ranged from 0 to 100% in the first 24 h (mean: 20%, standard deviation: 20%). Focal to bilateral tonic-clonic seizures and lorazepam administration occurred at a lower median AED dose than did FS (0%, 7.2%, and 43.8%, respectively, expressed as a percentage of the patient's outpatient daily AED dose; p < 0.001). A daily EMU-administered dose of one-third of the patient's outpatient AED dose allowed 55.0% of FS to occur while avoiding 82.0% of more severe seizure types. The seizure types had no difference in rate of AED withdrawal in the first 24 h of EMU stay. CONCLUSIONS: Focal seizures occurred at a higher AED dose than did f-BTCS. This may imply that a low minimally effective dose of AED could allow FS to be recorded while providing protection against f-BTCS. This strategy could improve efficacy and safety in the EMU.


Asunto(s)
Anticonvulsivantes/efectos adversos , Electroencefalografía/efectos de los fármacos , Epilepsia/fisiopatología , Monitoreo Fisiológico/métodos , Convulsiones/fisiopatología , Síndrome de Abstinencia a Sustancias/fisiopatología , Adolescente , Adulto , Anciano , Anticonvulsivantes/uso terapéutico , Niño , Electroencefalografía/métodos , Epilepsia/diagnóstico , Epilepsia/tratamiento farmacológico , Femenino , Unidades Hospitalarias , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Convulsiones/diagnóstico , Convulsiones/tratamiento farmacológico , Índice de Severidad de la Enfermedad , Síndrome de Abstinencia a Sustancias/diagnóstico , Adulto Joven
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda